Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

American Biogenetic Sciences obtains antibody technology from MRC

June 28, 1996

Collaboration for oral insulin formulation development

June 28, 1996

Techniclone's TNT to undergo clinical trials

June 28, 1996

Alizyme issued BTG license option

June 28, 1996

Hoechst, Hoechst Marion Roussel and Oncogene Science extend collaboration

June 28, 1996

Oxford Molecular Group and Alizyme begin research collaboration

June 28, 1996

Boston Life Science holds patent rights to C-Maf

June 28, 1996

3-D IMP dehydrogenase structure solved

June 28, 1996

Gensia receives first payment from Pfizer

June 28, 1996

Ciba-Geigy and Synaptic extend collaboration

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...